Among the major issues were tariff policies, reimbursement pathways for multi-cancer early detection tests, and reform of the ...

BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

NEW YORK – Diasorin said on Tuesday that the Liaison QuantiFeron-TB Gold Plus II assay developed in partnership with Qiagen has received premarket approval from the US Food and Drug Administration.

NEW YORK – Laboratory Corporation of America said Monday that it is deploying PathAI's AISight Dx digital pathology platform across its national network of anatomic pathology labs and hospital ...

Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.

The company will begin sales of the test in a small number of community oncology centers and expand to dozens of practices before full commercial launch next year.